I Nehring1, K Kewitz2, R von Kries1, U Thyen2. 1. Division of Epidemiology, Institute for Social Paediatrics and Adolescent Medicine, Ludwig-Maximilians-Universität München, Munich, Germany. 2. Department of Paediatric and Adolescent Medicine, University of Lübeck, Lübeck, Germany.
Abstract
BACKGROUND/ OBJECTIVE: Anorexia nervosa (AN) is a severe eating disorder with a high mortality rate. Treatment regimes show regional and global variation and are sometimes supported by enteral feeding (EF) via nasogastric tube, although risks and benefits are still unclear. We aimed to find out whether EF improves growth and AN recovery and prevents psychiatric comorbidities. SUBJECTS/ METHODS: Data were retrospectively collected from medical records and follow-up data were collected via questionnaires. Two hundred and eight female AN patients who were hospitalized below the age of 18 years with a mean follow-up of 6 years were analyzed. We calculated relative risks for the association between EF and suboptimal growth, remission of AN and the occurrence of psychiatric comorbidities, adjusting for potential confounders. RESULTS: A third of the analyzed girls received EF at any time. In the adjusted analyses, we found no significant associations between EF and suboptimal growth, the persistence of AN and the occurrence of psychiatric comorbidities, respectively. CONCLUSION: Our data suggest EF to be neither a risk factor nor beneficial for growth, recovery or persistence of AN and the occurrence of psychiatric comorbidities.
BACKGROUND/ OBJECTIVE:Anorexia nervosa (AN) is a severe eating disorder with a high mortality rate. Treatment regimes show regional and global variation and are sometimes supported by enteral feeding (EF) via nasogastric tube, although risks and benefits are still unclear. We aimed to find out whether EF improves growth and AN recovery and prevents psychiatric comorbidities. SUBJECTS/ METHODS: Data were retrospectively collected from medical records and follow-up data were collected via questionnaires. Two hundred and eight female AN patients who were hospitalized below the age of 18 years with a mean follow-up of 6 years were analyzed. We calculated relative risks for the association between EF and suboptimal growth, remission of AN and the occurrence of psychiatric comorbidities, adjusting for potential confounders. RESULTS: A third of the analyzed girls received EF at any time. In the adjusted analyses, we found no significant associations between EF and suboptimal growth, the persistence of AN and the occurrence of psychiatric comorbidities, respectively. CONCLUSION: Our data suggest EF to be neither a risk factor nor beneficial for growth, recovery or persistence of AN and the occurrence of psychiatric comorbidities.
Authors: Juliet N Zuercher; Edward J Cumella; Brenda K Woods; Marian Eberly; Janet K Carr Journal: JPEN J Parenter Enteral Nutr Date: 2003 Jul-Aug Impact factor: 4.016
Authors: Laura K Fischer; Colleen C Schreyer; Allisyn Pletch; Marita Cooper; Irina A Vanzhula; Graham W Redgrave; Angela S Guarda Journal: Eat Weight Disord Date: 2022-08-22 Impact factor: 3.008